105 related articles for article (PubMed ID: 11803351)
1. A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures.
Mishra V; Vaaler S; Brinch L
Bone Marrow Transplant; 2001 Dec; 28(12):1111-6. PubMed ID: 11803351
[TBL] [Abstract][Full Text] [Related]
2. A comparison of actual registered costs and costs derived from diagnosis-related groups (DRGs) for patients undergoing heart transplantation, lung transplantation, and thoracotomy for other lung diseases.
Mishra V; Skeie B; Vaaler S; Amlie E
Transpl Int; 2001 Dec; 14(6):361-9. PubMed ID: 11793033
[TBL] [Abstract][Full Text] [Related]
3. A comparison of actual cost, DRG-based cost, and hospital reimbursement for liver transplant patients.
Skeie B; Mishra V; Vaaler S; Amlie E
Transpl Int; 2002 Oct; 15(9-10):439-45. PubMed ID: 12389074
[TBL] [Abstract][Full Text] [Related]
4. Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.
Mishra V; Geiran O; Krohg-Sørensen K; Andresen S
Scand Cardiovasc J; 2008 Feb; 42(1):77-84. PubMed ID: 18273734
[TBL] [Abstract][Full Text] [Related]
5. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
[TBL] [Abstract][Full Text] [Related]
6. Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study.
Mishra V; Andresen S; Brinch L; Kvaløy S; Ernst P; Lønset MK; Tangen JM; Wikelund J; Flatum C; Baggerød E; Helle B; Vaaler S; Hagen TP
Bone Marrow Transplant; 2005 Jun; 35(12):1149-53. PubMed ID: 15880133
[TBL] [Abstract][Full Text] [Related]
7. Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.
Blommestein HM; Verelst SG; Huijgens PC; Blijlevens NM; Cornelissen JJ; Uyl-de Groot CA
Ann Hematol; 2012 Dec; 91(12):1945-52. PubMed ID: 22864761
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R
Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141
[TBL] [Abstract][Full Text] [Related]
9. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.
Cordonnier C; Maury S; Esperou H; Pautas C; Beaune J; Rodet M; Lagrange JL; Rouard H; Beaumont JL; Bassompierre F; Glückman E; Kuentz M; Durand-Zaleski I
Bone Marrow Transplant; 2005 Oct; 36(7):649-54. PubMed ID: 16044135
[TBL] [Abstract][Full Text] [Related]
10. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
11. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices.
Mishra V; Geiran O; Fiane AE; Sørensen G; Andresen S; Olsen EK; Khushi I; Hagen TP
J Heart Lung Transplant; 2010 Jan; 29(1):72-8. PubMed ID: 19783175
[TBL] [Abstract][Full Text] [Related]
12. [High-risk pregnancy, costs and DRG reimbursement].
Mathisen AB; Vaaler S; Dramstad E; Abyholm T
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):503-6. PubMed ID: 11961980
[TBL] [Abstract][Full Text] [Related]
13. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
[TBL] [Abstract][Full Text] [Related]
14. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
15. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital.
Ngamkiatphaisan S; Sriratanaban J; Kamolratanakul P; Intragumtornchai T; Noppakun N; Jongudomsuk P
J Med Assoc Thai; 2007 Dec; 90(12):2565-73. PubMed ID: 18386705
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
19. [How does the German DRG system differentiate and reimburse vitreoretinal surgery in diabetic patients?].
Krause M; Goldschmidt AJ; Berg M; Kropf S; Sachs A; Gatzioufas Z; Brückner K; Seitz B
Klin Monbl Augenheilkd; 2008 Oct; 225(10):880-7. PubMed ID: 18951309
[TBL] [Abstract][Full Text] [Related]
20. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
